Clinical Trial Details

Randomized Phase III Trial of Mfolfirinox +/- Nivolumab for First-Line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma

IRB Protocol Number
A022102

Clinical Trial Categories

  • Gastric Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: 

  • No prior systemic treatment for metastatic disease
  • ECOG performance status 0 or 1

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.